DIP
REGN icon

DT Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

DT Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24K Hold
10
– – ﹤0.01% 432
2026
Q1 		$7.73K Hold
10
– – ﹤0.01% 411
2025
Q4 		$7.72K Hold
10
– – ﹤0.01% 441
2025
Q3 		$5.62K Hold
10
– – ﹤0.01% 466
2025
Q2 		$5.25K Hold
10
– – ﹤0.01% 464
2025
Q1 		$6.34K Hold
10
– – ﹤0.01% 457
2024
Q4 		$7.12K Hold
10
– – ﹤0.01% 454
2024
Q3 		$10.5K Buy
+10
New +$11.1K ﹤0.01% 439

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

DT Investment Partners's REGN Position: Q2 2026 in Review

DT Investment Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 10 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

DT Investment Partners first reported a position in REGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.5K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • DT Investment Partners held 10 shares of Regeneron Pharmaceuticals worth $6.24K as of Q2 2026.
  • DT Investment Partners left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #432 holding.
  • DT Investment Partners first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • DT Investment Partners's Regeneron Pharmaceuticals position peaked at $10.5K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.